Hogarty, M. D., Ziegler, D. S., Franson, A., Chi, Y., Tsao‐Wei, D., Liu, K., . . . Marachelian, A. (2024). Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: A New Approaches to Neuroblastoma Therapy trial.
Citace podle Chicago (17th ed.)Hogarty, Michael D., et al. Phase 1 Study of High-dose DFMO, Celecoxib, Cyclophosphamide and Topotecan for Patients with Relapsed Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial. 2024.
Citace podle MLA (9th ed.)Hogarty, Michael D., et al. Phase 1 Study of High-dose DFMO, Celecoxib, Cyclophosphamide and Topotecan for Patients with Relapsed Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial. 2024.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..